House dust mite-specific immunotherapy alters the basal expression of T regulatory and FcεRI pathway genes

International Archives of Allergy and Immunology

Volumn 159, Issue 3, 2012, Pages 287-296

  Pevec, Branko ^a   Radulovic Pevec, Mira ^a   Stipic Markovic, Asja ^a   Batista, Irena ^a   Rijavec, Matija ^b   Silar, Mira ^b   Kosnik, Mitja ^b   Korosec, Peter ^b  

^a University Hospital Sveti Duh   (Croatia)

^b UNIVERSITY CLINIC OF RESPIRATORY AND ALLERGIC DISEASES   (Slovenia)

Author keywords

Gene expression; House dust mite; Specific immunotherapy

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; FC EPSILON RI; FC RECEPTOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN FC FRAGMENT; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE SYK; PROTEIN TYROSINE PHOSPHATASE SHP; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOPHAGOIDES; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH1 CELL; TH2 CELL; VISUAL ANALOG SCALE;

ADULT; ALLERGENS; ANIMALS; CASE-CONTROL STUDIES; COMPLEX MIXTURES; DERMATOPHAGOIDES PTERONYSSINUS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; IMMUNOTHERAPY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; NASAL PROVOCATION TESTS; PHOSPHORIC MONOESTER HYDROLASES; PROTEIN-TYROSINE KINASES; RECEPTORS, IGE; RNA, MESSENGER; SIGNAL TRANSDUCTION; SKIN TESTS; T-BOX DOMAIN PROTEINS; T-LYMPHOCYTES, REGULATORY;

EID: 84862503940     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000338289     Document Type: Article

References (50)

1. Akdis CA, Akdis M: Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. J Allergy Clin Immunol 2009; 123: 735-746
2. Amsen D, Spilianakis CG, Flavell RA: How are T H 1 and T H 2 effector cells made? Curr Opin Immunol 2009; 21: 153-160
3. Akdis M: Immune tolerance in allergy. Curr Opin Immunol 2009; 21: 700-707
4. Miyara M, Wing K, Sakaguchi S: Therapeutic approaches to allergy and autoimmunity based on FoxP3 + regulatory T-cell activation and expansion. J Allergy Clin Immunol 2009; 123: 749-755
5. Sakaguchi S, Yamaguchi T, Nomura T, Ono M: Regulatory T cells and immune tolerance. Cell 2008; 133: 775-787
6. Taylor A, Verhagen J, Akdis CA, Akdis M: T regulatory cells and allergy. Microbes Infect 2005; 7: 1049-1055
7. Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, McGrady G, Wahl SM: Conversion of peripheral CD4 + CD25 - naive T cells to CD4 + CD25 + regulatory T cells by TGF- - induction of transcription factor Foxp3. J Exp Med 2003; 198: 1875-1886
8. Rivera J, Fierro NA, Olivera A, Suzuki R: New insights on mast cell activation via the high affinity receptor for IgE. Adv Immunol 2008; 98: 85-120
9. Abramson J, Pecht I: Regulation of the mast cell response to the type 1 Fc - receptor. Immunol Rev 2007; 217: 231-254
10. Kambayashi T, Koretzky GA: Proximal signaling events in Fc - RI-mediated mast cell activation. J Allergy Clin Immunol 2007; 119: 544-552
11. Siraganian RP, de Castro RO, Barbu EA, Zhang J: Mast cell signaling: The role of protein tyrosine kinase Syk, its activation and screening methods for new pathway participants. FEBS Lett 2010; 584: 4933-4940
12. Gilfillan AM, Rivera J: The tyrosine kinase network regulating mast cell activation. Immunol Rev 2009; 228: 149-169
13. Rivera J, Olivera A: Src family kinases and lipid mediators in control of allergic inflammation. Immunol Rev 2007; 217: 255-268
14. Huber M, Helgason CD, Damen JE, Liu L, Humphries RK, Krystal G: The Src homology 2-containing inositol phosphatase (SHIP is the gatekeeper of mast cell degranulation. Proc Natl Acad Sci USA 1998; 95: 11330- 11335
15. Huber M, Kalesnikoff J, Reth M, Krystal G: The role of SHIP in mast cell degranulation and IgE-induced mast cell survival. Immunol Lett 2002; 82: 17-21
16. Dreborg S, Frew A (eds): Allergen standardization and skin tests - position paper from the European Academy of Allergology and Clinical Immunology. Allergy 1993; 48(suppl 14):48-82
17. Melillo G, Bonini S, Cocco G, Davies RJ, de Monchy JG, Frølund L, Pelikan Z: EAACI provocation tests with allergens. Report prepared by the European Academy of Allergology and Clinical Immunology Subcommittee on provocation tests with allergens. Allergy 1997; 52(suppl 35):1-35
18. Pichler CE, Marquardsen A, Sparholt S, Løwenstein H, Bircher A, Bischof M, Pichler WJ: Specific immunotherapy with Dermatophagoides pteronyssinus and D. farinae results in decreased bronchial hyperreactivity. Allergy 1997; 52: 274-283
19. Pichler CE, Helbling A, Pichler WJ: Three years of specific immunotherapy with house-dust-mite extracts in patients with rhinitis and asthma: significant improvement of allergen-specific parameters and of nonspecific bronchial hyperreactivity. Allergy 2001; 56: 301-306
20. Pifferi M, Baldini G, Marrazzini G, Baldini M, Ragazzo V, Pietrobelli A, Boner AL: Benefits of immunotherapy with a standardized Dermatophagoides pteronyssinus extract in asthmatic children: A three-year prospective study. Allergy 2002; 57: 785-790
21. Grembiale RD, Camporota L, Naty S, Tranfa CM, Djukanovic R, Marsico SA: Effects of specific immunotherapy in allergic rhinitic individuals with bronchial hyperresponsiveness. Am J Respir Crit Care Med 2000; 162: 2048-2052
22. Pajno GB, Barberio G, De Luca F, Morabito L, Parmiani S: Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy 2001; 31: 1392-1397
23. Inal A, Altintas DU, Yilmaz M, Karakoc GB, Kendirli SG, Sertdemir Y: Prevention of new sensitizations by specific immunotherapy in children with rhinitis and/or asthma monosensitized to house dust mite. J Investig Allergol Clin Immunol 2007; 17: 85-91
24. Benjaponpitak S, Oro A, Maguire P, Marinkovich V, DeKruyff RH, Umetsu DT: The kinetics of change in cytokine production by CD4 + T cells during conventional allergen immunotherapy. J Allergy Clin Immunol 1999; 103: 468-475
25. Tabar AI, Echechipía S, García BE, Olaguibel JM, Lizaso MT, Gómez B, Aldunate MT, Martin S, Marcotegui F: Double-blind comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus . J Allergy Clin Immunol 2005; 116: 109-118
26. Guimarães Junqueira de Queirós M, Oliveira Silva DA, Alves R, Fukuhara Chiba H, Soares de Amaral VB, de Almeida KC, Ynoue LH, de Oliveira Resende R, Camargo Sopelete M, Rodrigues Silva Segundo G, Ferreira de Sousa Moreira P, Sung SJ, Taketomi EA: Mitespecific immunotherapy using allergen and/ or bacterial extracts in atopic patients in Brazil. J Investig Allergol Clin Immunol 2008; 18: 84-92
27. Antúnez C, Mayorga C, Corzo JL, Jurado A, Torres MJ: Two year follow-up of immunological response in mite-allergic children treated with sublingual immunotherapy. Comparison with subcutaneous administration. Pediatr Allergy Immunol 2008; 19: 210- 218.
28. Tsai YG, Chien JW, Chen WL, Shieh JJ, Lin CY: Induced apoptosis of Th2 lymphocytes in asthmatic children treated with Dermatophagoides pteronyssinus immunotherapy. Pediatr Allergy Immunol 2005; 16: 602-608
29. Radulovic S, Jacobson MR, Durham SR, Nouri-Aria KT: Grass pollen immunotherapy induces Foxp3-expressing CD4 + CD25 + cells in the nasal mucosa. J Allergy Clin Immunol 2008; 121: 1467-1472
30. Askenasy N, Kaminitz A, Yarkoni S: Mechanisms of T regulatory cell function. Autoimmun Rev 2008; 7: 370-375
31. Tran DQ, Ramsey H, Shevach EM: Induction of FOXP3 expression in naive human CD4 + FOXP3 - T cells by T-cell receptor stimulation is transforming growth factor - dependent but does not confer a regulatory phenotype. Blood 2007; 110: 2983-2990
32. Wang J, Ioan-Facsinay A, van der Voort EI, Huizinga TW, Toes RE: Transient expression of FOXP3 in human activated nonregulatory CD4 + T cells. Eur J Immunol 2007; 37: 129- 138
33. Allan SE, Crome SQ, Crellin NK, Passerini L, Steiner TS, Bacchetta R, Roncarolo MG, Levings MK: Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 2007; 19: 345-354
34. Allan SE, Song-Zhao GX, Abraham T, Mc- Murchy AN, Levings MK: Inducible reprogramming of human T cells into Treg cells by a conditionally active form of FOXP3. Eur J Immunol 2008; 38: 3282-3289
35. Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, Niwa A, Parizot C, Taflin C, Heike T, Valeyre D, Mathian A, Nakahata T, Yamaguchi T, Nomura T, Ono M, Amoura Z, Gorochov G, Sakaguchi S: Functional delineation and differentiation dynamics of human CD4 + T cells expressing the FoxP3 transcription factor. Immunity 2009; 30: 899-911
36. Kepley CL, Youssef L, Andrews RP, Wilson BS, Oliver JM: Syk deficiency in nonreleaser basophils. J Allergy Clin Immunol 1999; 104: 279-284
37. Kumar P, Singh B, Lal R, Rembhotkar GW, Singh AB: Histamine releasibility and expression of Lyn and Syk kinases in Indian subjects and role of less potent IL-3 in nonreleaser basophils. Cytokine 2007; 37: 200- 205
38. MacGlashan DW Jr: Relationship between spleen tyrosine kinase and phosphatidylinositol 5 - phosphatase expression and secretion from human basophils in the general population. J Allergy Clin Immunol 2007; 119: 626-633
39. Saini SS, Paterniti M, Vasagar K, Gibbons SP Jr, Sterba PM, Vonakis BM: Cultured peripheral blood mast cells from chronic idiopathic urticaria patients spontaneously degranulate upon IgE sensitization: Relationship to expression of Syk and SHIP-2. Clin Immunol 2009; 132: 342-348
40. MacGlashan D Jr, Xia HZ, Schwartz LB, Gong J: IgE-regulated loss, not IgE-regulated synthesis, controls expression of Fc - RI in human basophils. J Leukoc Biol 2001; 70: 207-218
41. MacGlashan DW Jr: Endocytosis, recycling, and degradation of unoccupied Fc - RI in human basophils. J Leukoc Biol 2007; 82: 1003- 1010
42. MacGlashan D Jr, Miura K: Loss of Syk kinase during IgE-mediated stimulation of human basophils. J Allergy Clin Immunol 2004; 114: 1317-1324
43. Yanagi S, Inatome R, Takano T, Yamamura H: Syk expression and novel function in a wide variety of tissues. Biochem Biophys Res Commun 2001; 288: 495-498
44. Berton G, Mócsai A, Lowell CA: Src and Syk kinases: Key regulators of phagocytic cell activation. Trends Immunol 2005; 26: 208-214
45. Yanagi S, Sada K, Tohyama Y, Tsubokawa M, Nagai K, Yonezawa K, Yamamura H: Translocation, activation and association of protein- tyrosine kinase (p72Syk) with phosphatidylinositol 3-kinase are early events during platelet activation. Eur J Biochem 1994; 224: 329-333
46. Anderson RA, Boronenkov IV, Doughman SD, Kunz J, Loijens JC: Phosphatidylinositol phosphate kinases, a multifaceted family of signaling enzymes. J Biol Chem 1999; 274: 9907-9910
47. Rameh LE, Cantley LC: The role of phosphoinositide 3-kinase lipid products in cell function. J Biol Chem 1999; 274: 8347-8350
48. Rauh MJ, Kalesnikoff J, Hughes M, Sly L, Lam V, Krystal G: Role of Src homology 2-containing-inositol 5 - -phosphatase (SHIP in mast cells and macrophages. Biochem Soc Trans 2003; 31: 286-291
49. Krystal G: Lipid phosphatases in the immune system. Semin Immunol 2000; 12: 397- 403
50. Leung WH, Tarasenko T, Bolland S: Differential roles for the inositol phosphatase SHIP in the regulation of macrophages and lymphocytes. Immunol Res 2009; 43: 243-251.